Clinical updates, including trial initiations, enrollment status and data readouts and publications: 180 Life Sciences, Acasti, Amgen, Arbutus, Arca, Bonus, Hepagene, Humanigen, India Globalization, Immutep, Karyopharm, Redhill, Revelation, Spago, VBI, Ysopia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boston Scientific, Sophia Genetics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Acadia, Accutar, Arch, Biogen, Ciclomed, Clene, Compass, Edesa, G1, Immunomic, Insilico, J&J, Lintonpharm, Longeveron, Lynk, Mina, Modus, Notable, Oncotelic, Peptilogics, Pulmotech, Rallybio, SAB, Sage, Scholar Rock, Selecta, Sobi, Vertex, Virios, Zai, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Memed, Seno.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Allakos, Anji, Astrazeneca, Axial, Blade, Daiichi, Ensysce, First Wave, Hoth, Immunogen, IMV, Isarna, Jazz, Kintara, Kyowa, Mei, Mereo, Nicox, Olema, Ose, Seres, Synact, Visus.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akston, Arctic Vision, Astrazeneca, Beigene, Biontech, Daiichi Sankyo, Hutchmed, Innovent, Oncotelic, Pfizer, Pulmonem, Syneurx, Tennor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Artio Medical, Dia Imaging, Nevro, Relievant Medsystems, Quit Genius.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Betterlife, Biocryst, Brainstorm, Clover, G1 Therapeutics, Kineta, Kronos, Krystal, Merck & Co., Neurana, Nrx, RDIF, Ridgeback, Springworks, Starpharma, Tetra, Ultragenyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akcea, Astrazeneca, Avrobio, Cytodyn, Gilead, Hutchmed, Index, Ionis, Merck & Co., Pfizer.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aopeng, Castle Biosciences, Median Technologies.